Jean Senemaud

Dr. Jean Senemaud

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
JSJean Senemaud
Jean Senemaud
ARArnaud Roussel
Arnaud Roussel
QPQuentin Pellenc
Quentin Pellenc
CCCatherine Chardigny
Catherine Chardigny
PCPierre Cerceau
Pierre Cerceau
YCYves Castier
Yves Castier

28 August 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
JSJean Senemaud
Jean Senemaud
AGAurelie Gouel-Cheron
Aurelie Gouel-Cheron
CTChloé Tesmoingt
Chloé Tesmoingt
EBEliza Barret
Eliza Barret
PMphilippe montravers
philippe montravers
YCYves Castier
Yves Castier

17 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JSJean Senemaud
Jean Senemaud
MGMARINE GAUDRY
MARINE GAUDRY
EJElisabeth Jouve
Elisabeth Jouve
ABArnaud Blanchard
Arnaud Blanchard
OMOlivier Milleron
Olivier Milleron
LBLaurence Bal
Laurence Bal
Purpose: The study sought to estimate the prevalence of primary non-aortic lesions (PNAL) unrelated to extension of aortic dissection (AD) in a cohort of patients with Marfan syndrome (MFS). Methods: Adult patients presenting with pathogenic FBN1 mutations and an available pan-aortic contrast-enhanced CTA in eight French MFS clinics from April to October 2018 were included. Clinical and radiological data, particularly the presence of aortic lesions and PNAL (including aneurysm and ectasia), were retrospectively analyzed. Results: Out of 138 patients, 28 (20.3%) had PNAL. In total, 27 aneurysms in 13 patients and 41 ectasias in 19 patients were reported mainly in the subclavian, iliac, and vertebral segments. Four patients (31%) with aneurysms and none with ectasia required prophylactic intervention during follow-up (median: 46 months). In multivariate analysis, factors associated with PNAL were history of AD (OR = 3.9, 95%CI: 1.3–12.1, p = 0.018), history of previous descending aortic surgery (OR = 10.3, 95%CI: 2.2–48.3, p = 0.003) and age (per 10 years OR = 1.6, 95%CI: 1.1–2.4, p = 0.008). Conclusion: PNAL is not rare in MFS patients with evolutive aortic disease. Natural history may differ between aneurysms and ectasia, emphasizing the need for standardized definitions and systematic screening for PNAL.

6 September 2024 in Seminars in Vascular Surgery
Verified
Journal Article
Closed access
GSGabrielle Stevenin
Gabrielle Stevenin
JCJennifer Canonge
Jennifer Canonge
MGMarianne Gervais
Marianne Gervais
AFAntonio Fiore
Antonio Fiore
FLFabien Lareyre
Fabien Lareyre
JSJean Senemaud
Jean Senemaud

21 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZHZhuo HUANG
Zhuo HUANG
CSCharles Skarbek
Charles Skarbek
YLYulin Li
Yulin Li
JTJoseph Touma
Joseph Touma
PDPascal Desgranges
Pascal Desgranges
JSJean Senemaud
Jean Senemaud
Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide, affecting more than 300 million people. Over the past two decades, percutaneous coronary intervention (PCI) has become the cornerstone of CAD treatment, involving the implantation of coronary stents. This review clarifies how coronary stents emerged, evolved, and ultimately reshaped modern interventional cardiology. Beginning with balloon angioplasty and progressing through bare-metal and drug-eluting stents, we show how each advancement solved key clinical shortcomings—dramatically reducing restenosis, thrombosis, and repeat revascularization. We further review the major technological advances driving modern stent development, such as biodegradable alloys and biomimetic coatings. We also highlight the remaining challenges, including long-term stability, manufacturing complexity, and limited translational readiness. Together, these elements support our central thesis: that the historical evolution of coronary stents is fundamental to understanding present PCI practice and to guiding the next phase of device innovation.

1 December 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
JSJean Senemaud
Jean Senemaud
RCRaphael Coscas
Raphael Coscas
JAJean-Marc Alsac
Jean-Marc Alsac
YCYves Castier
Yves Castier
QPQuentin Pellenc
Quentin Pellenc
JMJean-Baptiste Michel
Jean-Baptiste Michel